Jorma Lahtela - Concepedia

Author

Jorma Lahtela

Also Known As

J Lahtela, J T Lahtela, J. Lahtela, J. T. Lahtela, J.T. Lahtela, JT Lahtela, Jorma Lahtela, Jorma T Lahtela, Jorma T. Lahtela, Pirkko Korsoff

108

Publications

Citations

H-Index

Concepts

All Affiliations

Tampere University Hospital Tampere University University of Helsinki University of Oulu

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1.4K
2	Health Sciences	5	5	97
3	Public Health	5	5	167
4	Business	1	1	35
5	Management	1	1	35

Jorma Lahtela

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, The Lancet UrologyRenal DiseaseRenal EventsRenal FunctionDiabetes	2019	589
Effect of Lifestyle Intervention on the Occurrence of Metabolic Syndrome and its Components in the Finnish Diabetes Prevention Study Pirjo Ilanne‐Parikka, Johan G. Eriksson, Jaana Lindström, Diabetes Care	2008	218
Prevalence of the Metabolic Syndrome and Its Components Pirjo Ilanne‐Parikka, Johan G. Eriksson, Jaana Lindström, Diabetes Care	2004	198
Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study Teemu J. Murtola, Teuvo L.J. Tammela, Jorma Lahtela, Cancer Epidemiology Biomarkers & Prevention	2007	189
Self‐reported non‐severe hypoglycaemic events in Europe C. G. Östenson, Petronella Geelhoed-Duijvestijn, Jorma Lahtela, Diabetic Medicine	2013	169
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial Matthias von Herrath, Stephen C. Bain, Bruce W. Bode, The Lancet Diabetes & Endocrinology Inflammationβ-Cell FunctionDiabetes ManagementAnti-interleukin-21 AntibodyDiabetes	2021	163
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani, The Lancet HypertensionRenal FunctionRenal DiseaseMedicineKidney Failure	2023	151
Long-term outcome and quality of life in patients with Charcot foot Toni-Karri Pakarinen, Heikki-Jussi Laine, Heikki Mäenpää, Foot and Ankle Surgery Lower Extremity WoundLong-term OutcomeLower Limb TraumaSurgeryRehabilitation	2009	120
Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study Teemu J. Murtola, Teuvo L.J. Tammela, Jorma Lahtela, American Journal of Epidemiology	2008	106
Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled trial Andrew Ahmann, Helena W. Rodbard, Julio Rosenstock, Diabetes Obesity and Metabolism	2015	98

Page 1